EP Wealth Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History

EP Wealth Advisors’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,360	Closed	-$305K	–	576
2021 Q3	$305K	Buy	+17,360	New	+$203K	0.01%	426

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

EP Wealth Advisors's TRIL Position: Q4 2021 in Review

EP Wealth Advisors sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 17,360 shares — an estimated $305K sold.

EP Wealth Advisors first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $305K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

EP Wealth Advisors reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
EP Wealth Advisors sold 17,360 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $305K.
EP Wealth Advisors first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
EP Wealth Advisors's Trillium Therapeutics Inc. position peaked at $305K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on EP Wealth Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.